National University Heart Centre, Singapore
12
4
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
8.3%
1 terminated/withdrawn out of 12 trials
50.0%
-36.5% vs industry average
25%
3 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE)
Role: collaborator
Acute Myocardial Infarction - Allied Health-Oriented Patient-centered Digitally-Enabled Care
Role: lead
CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial
Role: collaborator
PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE
Role: lead
AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication
Role: collaborator
Prospective Evaluation of Asians With CRT for Heart Failure
Role: lead
IMproving reModeling in Acute myoCardial Infarction Using Live and Asynchronous TElemedicine.
Role: lead
Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)
Role: collaborator
Effectiveness of Advanced Practice Nurse-Led Telehealth on Readmissions
Role: lead
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
Role: collaborator
Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
Role: collaborator
Sternal Closure With Biologic Bone Cement in Patients Undergoing Coronary Artery Bypass Grafting (CABG)
Role: lead
All 12 trials loaded